FDA Inspection 1180313 — Apotex Pharmachem India Pvt Ltd.
The FDA completed an inspection of Apotex Pharmachem India Pvt Ltd. on Sep 2, 2022 in Bangalore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 2, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bangalore (India)
Additional details
Clinical BA/BE